Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Boosted by Scotia Capital Inc.

Scotia Capital Inc. increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.1% during the 4th quarter, HoldingsChannel reports. The firm owned 5,166 shares of the medical equipment provider’s stock after acquiring an additional 204 shares during the period. Scotia Capital Inc.’s holdings in Intuitive Surgical were worth $2,697,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in ISRG. M.E. Allison & CO. Inc. bought a new position in shares of Intuitive Surgical during the fourth quarter worth about $449,000. Seilern Investment Management Ltd acquired a new position in Intuitive Surgical during the 4th quarter valued at about $82,517,000. Sycomore Asset Management grew its position in Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares during the last quarter. Exome Asset Management LLC increased its stake in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. raised its holdings in shares of Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after buying an additional 525 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 0.8 %

ISRG stock opened at $493.60 on Friday. The firm has a market capitalization of $175.81 billion, a PE ratio of 77.00, a P/E/G ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The firm has a 50-day moving average of $532.72 and a two-hundred day moving average of $532.36.

Wall Street Analyst Weigh In

Several analysts recently commented on ISRG shares. Wells Fargo & Company raised their target price on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Piper Sandler reissued an “overweight” rating and set a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Raymond James upped their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Leerink Partners raised their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Finally, Jefferies Financial Group upped their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $611.86.

Insiders Place Their Bets

In related news, CFO Jamie Samath sold 94 shares of the stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Fredrik Widman sold 810 shares of Intuitive Surgical stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $573.78, for a total value of $464,761.80. Following the transaction, the vice president now directly owns 473 shares in the company, valued at approximately $271,397.94. This trade represents a 63.13 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 33,754 shares of company stock worth $17,691,621. Corporate insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.